- PharmaCell B.V. -
PharmaCell is qualified for commercial production following MAA product approval and EMA inspection. Our facility holds all licensures for manufacturing under GMP conditions for Advanced Therapeutic Medicinal Products (ATMPs) registered under Investigational Medicinal Product Dossier (IMPD) for the European market.
PharmaCell maintains a cGMP compliant quality system and all documentation is in English.
This means that any product from any client can be GMP manufactured for clinical studies under this license and no separate license per product is required as long as an approved IMPD is provided to PharmaCell.